Δ 9 -Tetrahydrocannabinol Content of Commercially Available Hemp Products

By Holler Justin M.  

Journal of Analytical Toxicology, Vol. 32, Iss. 6, 2008-07 ,pp. : 428-432

Oxford University Press

Access to resources Recommend Favorite

An Automated and Simultaneous Solid-Phase Extraction of Δ 9 -Tetrahydrocannabinol and 11-Nor-9-Carboxy-Δ 9 -Tetrahydrocannabinol from Whole Blood Using the Zymark RapidTrace™ with Confirmation and Quantitation by GC–EI-MS

By D'Asaro John A.  

Journal of Analytical Toxicology, Vol. 24, Iss. 4, 2000-05 ,pp. : 289-295

Oxford University Press

Access to resources Recommend Favorite

Urinary Pharmacokinetics of 11-Nor-9-carboxy-Δ 9 -tetrahydrocannabinol after Controlled Oral Δ 9 -Tetrahydrocannabinol Administration

By Gustafson Richard A.  

Journal of Analytical Toxicology, Vol. 28, Iss. 3, 2004-04 ,pp. : 160-167

Oxford University Press

Access to resources Recommend Favorite

Simultaneous GC–EI-MS Determination of Δ 9 -Tetrahydrocannabinol, 11-Hydroxy-Δ 9 -Tetrahydrocannabinol, and 11-nor-9-Carboxy-Δ 9 -Tetrahydrocannabinol in Human Urine Following Tandem Enzyme-Alkaline Hydrolysis

By Abraham Tsadik T.  

Journal of Analytical Toxicology, Vol. 31, Iss. 8, 2007-10 ,pp. : 477-485

Oxford University Press

Access to resources Recommend Favorite

Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-Nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid

By Manno J.E.  

Journal of Analytical Toxicology, Vol. 25, Iss. 7, 2001-10 ,pp. : 538-549

Oxford University Press

Access to resources Recommend Favorite